Silicon Valley Provides $50MM Facility to Achaogen
Achaogen, a biopharmaceutical company, entered into a new secured credit facility with Silicon Valley Bank that provides up to $50 million of capital.
March 2, 2018
Achaogen | Jackie Spencer | Silicon Valley Bank
ABF Journal